The RCT by Walfisch et al. studied in colon cancer patients who were candidates for colectomy the potential effects of oral lycopene integration in reducing plasma levels of insulin-like growth factor-I (IGF-I), a recognized risk factor for various cancers including colon cancer. This evidence concerns the gene IGF1 and colonic neoplasm.